SEC Form 4 · accession 0001104659-18-053206
Neon Therapeutics, Inc. · NTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh O'Dowd
Officer — President & CEO · Director
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001694187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2018 | M | 18,868 | $2.65 | A | 445,868 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.65 | Aug 20, 2018 | M | 18,868 | D | — | — | Common Stock | 18,868 | 314,607 | D |
Explanation of responses
- F125% of the shares vested on September 23, 2017, with the remainder vesting over 36 equal monthly installments thereafter.
Remarks
Exhibit 24.1: Power of Attorney